May 24, 2021
In a fallout from Kobayashi Kako’s manipulated regulatory submission issue, the company’s three codevelopers were slapped with a business improvement order from Japanese regulators for seeking approval with data forged by the scandal-ravaged generic maker. The Ministry of Health, Labor...read more